A MAKEOVER AT NEOSTEMA MAKEOVER AT NEOSTEMBig plans by tiny NeoStem (NBS (National Bureau of Standards) See NIST. NBS - National Bureau of Standards: part of the US Department of Commerce, now NIST. ), which collects and stores adult stem cells for future medical use, have helped catapult its stock to 2.27 a share from 50 cents on Mar. 9. NeoStem applied for patent protection in May for a technology that allows use of an adult's stem cells stem cells, unspecialized human or animal cells that can produce mature specialized body cells and at the same time replicate themselves. Embryonic stem cells are derived from a blastocyst (the blastula typical of placental mammals; see embryo), which is very young in cosmetic surgery cosmetic surgery, plastic surgery for cosmetic purposes, such as the improvement of the appearance of the face by removing wrinkles or reshaping the nose. . And it took a 51% stake in a profitable Chinese drug company with $60 million in sales to distribute stem cell therapies in China. In April it raised $11 million in China to improve its balance sheet. It also signed a 10-year pact on June 15 with China's Enhanced Biomed Holdings to build stem cell stem cell In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult. treatment clinics in China. Rachel Kirsch kirsch n. A colorless brandy made from the fermented juice of cherries. [French, short for German Kirschwasser; see kirschwasser. of Pro-Active Research Group (it did business with NeoStem) rates the stock a speculative buy, seeing it at 5 in a year. Gary Goldstein, president of Mithra Research, says China operations should yield revenues of $50 million a year. His 12-month target: 7. Note: Unless otherwise noted, neither the sources cited in Inside Wall Street nor their firms hold positions in the stocks under discussion. Similarly, they have no investment banking or other financial relationships with them. 
|
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion